MIDATECH PHARMA ADS

Midatech announces changes in Senior Management Team

15 Mar 2018 08:02:03 By Nasdaq GlobeNewswire

Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency

28 Feb 2018 07:01:22 By Nasdaq GlobeNewswire

Midatech Pharma Plc: Trading update

14 Feb 2018 07:00:59 By Nasdaq GlobeNewswire

Midatech and UCSF receive IND approval for DIPG treatment MTX110

16 Jan 2018 07:01:20 By Nasdaq GlobeNewswire

Midatech receives confirmation that its Q-Octreotide (MTD201) first in-human EU study is approved

09 Jan 2018 07:01:34 By Nasdaq GlobeNewswire

Midatech Loan Agreement with MidCap Financial

02 Jan 2018 07:01:05 By Nasdaq GlobeNewswire

Midatech Pharma US initiates Gelclair® Phase IV trial to study oral mucositis in stem cell transplant patients

20 Dec 2017 07:01:07 By Nasdaq GlobeNewswire

Midatech Pharma Plc: Completion of pre-clinical liver cancer programme

26 Jul 2017 07:01:04 By Nasdaq GlobeNewswire

Midatech Pharma Plc: Trading Update and Notice of Results

18 Jul 2017 07:01:15 By Nasdaq GlobeNewswire

R&D manufacturing site visit for investors and analysts

13 Jun 2017 07:42:19 By Nasdaq GlobeNewswire

Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers

07 Jun 2017 11:15:42 By Nasdaq GlobeNewswire

Midatech Pharma PLC: Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility

10 Mar 2017 07:52:24 By Nasdaq GlobeNewswire

Midatech Pharma PLC: Trading Update

20 Jan 2017 08:03:30 By Nasdaq GlobeNewswire

Interim results for the six months ended 30 June 2016

02 Sep 2016 02:00:43 By Nasdaq GlobeNewswire